NuCana NCNA Q3 2024 Earnings EPS Surprise Beats Estimates Despite No Revenue KHC Q1 2026 Earnings EPS Surges Past Estimates Amid Cost Discipline Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage LAC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress on Thacker Pass VIVS Q3 2025 Earnings EPS Beat on Cost Management Amidst Ongoing Development OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance